Avion’s ₩79.4 Billion Rights Offering: Should You Invest? On August 29, 2025, Avion announced a significant rights offering. While securing funds for R&D is generally seen as positive, potential stock dilution warrants careful consideration. This article provides a comprehensive analysis of Avion’s rights offering, its implications for investors, and potential investment strategies. 1. What Happened … Read more
S&P Savings Bank massively sells ABION stock! Should you invest now? On August 11, 2025, news broke that S&P Savings Bank had massively sold its ABION stock, drawing attention from investors. How will this sale affect ABION’s future? In this article, we analyze the background of S&P Savings Bank’s massive sale and its impact, and … Read more
ABL Bio’s Warrant Exercise: Where is the Stock Price Headed? On July 25, 2025, ABL Bio announced the exercise of its warrants. While this raises concerns about short-term stock dilution, it also presents a positive aspect: securing long-term growth momentum. This article analyzes the impact of ABL Bio’s warrant exercise on its stock price from … Read more